Amphotericin B-induced nephrotoxicity: a review.
Amphotericin B is the gold standard for antifungal treatment for the most severe mycoses. However, adverse effects are common, with nephrotoxicity being the most serious, occurring early in the course of treatment, and usually being reversible in most patients. Tubular damage is a well known problem associated with amphotericin B therapy but acute renal failure is the most serious complication. Recent studies have examined ways to ameliorate the well-known toxicities of amphotericin B. A new approach has been to complex the drug with lipids or entrap it in liposomes. This review will concern amphotericin B-induced nephrotoxicity, whose mechanisms are not completely clear. Nephrotoxicity seems related to direct amphotericin B action on the renal tubules as well as to drug-induced renal vasoconstriction. The main mechanisms of nephrotoxicity suggested in the literature are presented. The clinical picture at different ages (adults, children, newborns), interactions of clinical significance, strategies for prevention of amphotericin B-induced nephrotoxicity are summarized. To provide optimal patient care, it is imperative that the clinician understand the etiology of and the signs and symptoms associated with nephrotoxicity, as well as interventions to prevent nephrotoxicity in patients receiving amphotericin B.
Fanos
V
V
Department of Pediatrics, Ospedale Policlinico, University of Verona, Italy. vafanos@tin.it
Cataldi
L
L
D000367:Age Factors; D000666:Amphotericin B / Q000009:adverse effects*; D000818:Animals; D000935:Antifungal Agents / Q000009:adverse effects*; D002463:Cell Membrane Permeability / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D007677:Kidney Function Tests; D014661:Vasoconstriction / Q000187:drug effects
D000935:Antifungal Agents; D000666:Amphotericin B